miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review.

miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review.
复制标题

DOI:
10.3390/ijms22094332
复制
发表时间:
2021-04-21
影响因子:
5.6
通讯作者:
Saluk-Bijak J
Saluk-Bijak J
中科院分区:
生物学2区
文献类型:
--
作者:
Maciak K;Dziedzic A;Miller E;Saluk-Bijak J

文献摘要

参考文献

被引文献

相似文献

多发性硬化症(MS)是一种慢性免疫介导的疾病,是年轻人残疾的主要原因。microRNA(miRNAs)参与基因表达的转录后调控。其中,miR-155是炎症的关键调节因子,并在调节MS中的自身免疫应答中起作用。miR-155通过在炎症条件下下调关键连接蛋白而参与血脑屏障(BBB)破坏。它通过促进,例如,小胶质细胞活化、星形胶质细胞极化、CD 47蛋白下调及影响关键转录因子。miR-155对神经性疼痛的发展具有巨大影响,并间接影响参与缓解疼痛超敏反应的调节性T(Treg)细胞分化。这篇综述还关注了由于疾病相关应激源、脑萎缩和促炎因子而出现的神经精神症状。最近的研究揭示了miR-155在调节焦虑、应激、海马体炎症和难治性抑郁症中的作用。抑制miR-155的表达被证明是有效的,在预防MS的病理生理过程中所涉及的。这篇综述旨在支持更好地理解miR-155失调在MS病理生理的各个方面的巨大作用,并突出了这种分子的未来前景。
Multiple sclerosis (MS) is a chronic, immune-mediated disease and the leading cause of disability among young adults. MicroRNAs (miRNAs) are involved in the post-transcriptional regulation of gene expression. Of them, miR-155 is a crucial regulator of inflammation and plays a role in modulating the autoimmune response in MS. miR-155 is involved in blood–brain barrier (BBB) disruption via down-regulation of key junctional proteins under inflammatory conditions. It drives demyelination processes by contributing to, e.g., microglial activation, polarization of astrocytes, and down-regulation of CD47 protein and affecting crucial transcription factors. miR-155 has a huge impact on the development of neuropathic pain and indirectly influences a regulatory T (Treg) cell differentiation involved in the alleviation of pain hypersensitivity. This review also focused on neuropsychiatric symptoms appearing as a result of disease-associated stressors, brain atrophy, and pro-inflammatory factors. Recent studies revealed the role of miR-155 in regulating anxiety, stress, inflammation in the hippocampus, and treatment-resistant depression. Inhibition of miR-155 expression was demonstrated to be effective in preventing processes involved in the pathophysiology of MS. This review aimed to support the better understanding the great role of miR-155 dysregulation in various aspects of MS pathophysiology and highlight future perspectives for this molecule.
DOI: 10.1111/j.1471-4159.2011.07572.x
发表时间: 2012-01
影响因子: 4.7
作者:
Choi SH;Aid S;Kim HW;Jackson SH;Bosetti F
通讯作者: Bosetti F
DOI: 10.1371/journal.pone.0013454
发表时间: 2010-10-26
期刊: PloS one
影响因子: 3.7
作者:
Field J;Browning SR;Johnson LJ;Danoy P;Varney MD;Tait BD;Gandhi KS;Charlesworth JC;Heard RN;Australia and New Zealand Multiple Sclerosis Genetics Consortium;Stewart GJ;Kilpatrick TJ;Foote SJ;Bahlo M;Butzkueven H;Wiley J;Booth DR;Taylor BV;Brown MA;Rubio JP;Stankovich J
通讯作者: Stankovich J
DOI: 10.1101/cshperspect.a020412
发表时间: 2015-01-01
影响因子: 7.2
作者:
Daneman, Richard;Prat, Alexandre
通讯作者: Prat, Alexandre
DOI: 10.3389/fncel.2015.00476
发表时间: 2015
影响因子: 5.3
作者:
Brites D;Fernandes A
通讯作者: Fernandes A
DOI: 10.1016/j.jare.2020.08.012
发表时间: 2021-03
影响因子: 10.7
作者:
Chakraborty C;Sharma AR;Sharma G;Lee SS
通讯作者: Lee SS